BSE filing, BSE: 541299. Summary written from the filing by ALFA Finder's alert engine.
Dr. Lalchandani Labs Ltd: key numbers
- Share price
- ₹6.95
- Market cap
- ₹6.02 Cr
- Revenue (annual)
- ₹4.19 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- 94.7×Sector 52.8×
- Promoter holding
- 32.90%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Lalchandani Labs Ltd
All →Dr. Lalchandani Labs Other Announcement
Dr Lalchandani Labs Ltd. received an extension from the Registrar of Companies to hold its AGM for FY 2025-26 by December 31, 2026.
Dr. Lalchandani Labs H2 FY26 Results: Net Loss of ₹0.1 Cr
Dr. Lalchandani Labs Ltd reported revenue from operations of ₹2.1 Cr (-8.7% YoY) and a net loss of ₹0.1 Cr for H2 FY26.
- Key figure
- Net loss ₹0.1 Cr
Dr. Lalchandani Labs Board Meeting Date
Dr Lalchandani Labs Limited postponed its May 30 board meeting to June 03, 2026. The delay allows for internal review of financial data before results approval.
Dr. Lalchandani Labs Capacity Expansion: ₹1 Cr Investment
Dr Lalchandani Labs opened a new strategic centre in Dwarka, Delhi. The facility targets a ₹1 Crore annual revenue contribution from local government employee residents.
- Value
- ₹1.00 Cr
Dr. Lalchandani Labs Other Announcement
Dr Lalchandani Labs Ltd confirmed it does not meet the 'Large Corporate' criteria for FY 2025-26 under SEBI debt-raising norms. The company reported zero incremental borrowings and no mandatory debt-sourcing requirements as its long-term borrowings remain below the Rs. 1000 crore threshold.
Dr. Lalchandani Labs Debt & Borrowing
Dr Lalchandani Labs Ltd confirmed it does not qualify as a Large Corporate entity for the financial year 2026. The company reported zero outstanding borrowings as of March 31, 2026, and is therefore not subject to SEBI's mandatory debt-raising framework for large entities.
Other board meeting date announcements
All →Max Estates Board Meeting Date
Max Estates Limited has informed exchanges that its board will meet on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 6 November 2026.
GKP Printing & Packaging Board Meeting Date
G.K.P. Printing & Packaging announced a board meeting on 4 November 2026 to approve unaudited results for the quarter ended 30 September 2026. Trading window has been closed for insiders since 1 October 2026.
ADF Foods Board Meeting Date
ADF Foods will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The meeting will also consider an interim dividend for FY2026-27.
MKP Mobility Board Meeting Date
MKP Mobility will hold a board meeting on November 6, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results.
Earkart Board Meeting Date
Earkart Limited gave prior intimation of a board meeting on 5 November 2026 to approve half-year results and incorporate an Australian subsidiary. The trading window stays closed until 7 November 2026.
Sabrimala Industries India Board Meeting Date
Sabrimala Industries India will hold a board meeting on 10 November 2026 to consider unaudited quarterly and half-year results. Trading window stays closed until 48 hours after results.